Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

NCT07027436 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: Chemotherapy/Radiation

Sponsor

Hamilton Health Sciences Corporation

Collaborators

[object Object]